Renato Alterini

1.4k total citations
42 papers, 840 citations indexed

About

Renato Alterini is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Renato Alterini has authored 42 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 15 papers in Oncology and 9 papers in Genetics. Recurrent topics in Renato Alterini's work include Lymphoma Diagnosis and Treatment (23 papers), Cutaneous lymphoproliferative disorders research (8 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Renato Alterini is often cited by papers focused on Lymphoma Diagnosis and Treatment (23 papers), Cutaneous lymphoproliferative disorders research (8 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Renato Alterini collaborates with scholars based in Italy and Taiwan. Renato Alterini's co-authors include Luigi Rigacci, Alberto Bosi, Valentina Carrai, Andrea Messori, Pierluigi Rossi Ferrini, Luca Nassi, Enrico Maggi, Sergio Romagnani, Nicola Pimpinelli and Riccardo Saccardi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Renato Alterini

42 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renato Alterini Italy 16 443 237 185 141 128 42 840
Anne Pham‐Ledard France 17 513 1.2× 454 1.9× 443 2.4× 239 1.7× 179 1.4× 72 1.0k
J. Zeffren United States 14 247 0.6× 177 0.7× 325 1.8× 77 0.5× 304 2.4× 18 772
Martha Glenn United States 15 334 0.8× 107 0.5× 275 1.5× 33 0.2× 138 1.1× 41 813
Chin-Yang Li United States 11 184 0.4× 103 0.4× 139 0.8× 66 0.5× 61 0.5× 14 579
Katalin Kelemen United States 16 220 0.5× 60 0.3× 185 1.0× 72 0.5× 245 1.9× 63 1.1k
Julia Valencak Austria 18 332 0.7× 169 0.7× 475 2.6× 156 1.1× 73 0.6× 38 939
Adam M. Petrich United States 17 554 1.3× 55 0.2× 388 2.1× 38 0.3× 127 1.0× 57 902
Kamel Laribi France 17 329 0.7× 140 0.6× 606 3.3× 88 0.6× 149 1.2× 62 1.2k
Ana‐Iris Schiefer Austria 18 217 0.5× 49 0.2× 199 1.1× 48 0.3× 102 0.8× 43 682
Grete F. Lauritzsen Norway 19 851 1.9× 174 0.7× 692 3.7× 34 0.2× 623 4.9× 34 1.4k

Countries citing papers authored by Renato Alterini

Since Specialization
Citations

This map shows the geographic impact of Renato Alterini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renato Alterini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renato Alterini more than expected).

Fields of papers citing papers by Renato Alterini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renato Alterini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renato Alterini. The network helps show where Renato Alterini may publish in the future.

Co-authorship network of co-authors of Renato Alterini

This figure shows the co-authorship network connecting the top 25 collaborators of Renato Alterini. A scholar is included among the top collaborators of Renato Alterini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renato Alterini. Renato Alterini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goteri, Gaia, Pietro Leoni, Giuliano Brandozzi, et al.. (2016). Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides. European Journal of Dermatology. 26(1). 13–20. 9 indexed citations
2.
Grandi, Vieri, Alessandro Pileri, Pietro Quaglino, et al.. (2012). Combination treatment in CTCL: the current role of bexarotene.. PubMed. 147(6). 573–80. 4 indexed citations
3.
Vultaggio, Alessandra, Andrea Matucci, Francesca Nencini, et al.. (2012). Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab. International Archives of Allergy and Immunology. 159(3). 321–326. 53 indexed citations
4.
Carrai, Valentina, Irene Donnini, Benedetta Mazzanti, et al.. (2012). Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation. Clinical Neurology and Neurosurgery. 115(7). 1044–1048. 6 indexed citations
5.
Rigacci, Luigi, Benedetta Puccini, Renato Alterini, et al.. (2011). Single dose palonosetron and dexamethasone in preventing nausea and vomiting induced by high emetogenic ABVD regimen in Hodgkin Lymphoma patients. Leukemia Research. 36(2). 182–185. 9 indexed citations
6.
Pulini, Stefano, Serena Rupoli, Gaia Goteri, et al.. (2008). Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B‐cell lymphomas and comparison with the commonly used therapies. European Journal Of Haematology. 82(3). 184–193. 14 indexed citations
7.
Pulini, Stefano, Serena Rupoli, Gaia Goteri, et al.. (2007). Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas. Haematologica. 92(5). 686–689. 40 indexed citations
8.
Rigacci, Luigi, Luca Nassi, Silvia Mappa, et al.. (2007). Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas. Annals of Hematology. 86(8). 565–568. 31 indexed citations
9.
10.
Zinzani, Pier Luigi, Pietro Quaglino, Nicola Pimpinelli, et al.. (2006). Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous Lymphomas. Journal of Clinical Oncology. 24(9). 1376–1382. 143 indexed citations
11.
12.
Rigacci, Luigi, Antonio Castagnoli, Renato Alterini, et al.. (2005). 18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: Long-term results. Oncology Reports. 14(5). 1209–14. 29 indexed citations
13.
Rigacci, Luigi, Massimo Federico, Maurizio Martelli, et al.. (2003). The Role of Anthracyclines in Combination Chemotherapy for the Treatment of Follicular Lymphoma: Retrospective Study of theIntergruppo Italiano Linfomion 761 Cases. Leukemia & lymphoma. 44(11). 1911–1917. 14 indexed citations
14.
15.
Vannucchi, Alessandro M., Alberto Bosi, P Pacini, et al.. (1998). Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT‐PCR for cytokeratin‐19 mRNA. British Journal of Haematology. 103(3). 610–617. 49 indexed citations
16.
Messori, Andrea, et al.. (1997). Cost-effectiveness of autologous bone marrow transplantation in patients with relapsed non-Hodgkin’s lymphoma. Bone Marrow Transplantation. 19(3). 275–281. 23 indexed citations
17.
Rigacci, Luigi, et al.. (1996). A new protocol (MiCEP) for the treatment of intermediate or high-grade non-hodgkin's lymphoma in the elderly. Leukemia & lymphoma. 20(5-6). 475–480. 8 indexed citations
18.
Alterini, Renato, et al.. (1996). Pseudo-Gaucher cells in the bone marrow of a patient with centrocytic nodular non-Hodgkin's lymphoma.. PubMed. 81(3). 282–3. 10 indexed citations
19.
Rigacci, Luigi, et al.. (1994). Combined Surgery and Chemotherapy in Primary Gastric Non-Hodgkin's Lymphoma: a Retrospective Study in Sixty-Six Patients. Leukemia & lymphoma. 14(5-6). 483–489. 10 indexed citations
20.
Alterini, Renato, et al.. (1989). Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas. British Journal of Cancer. 60(2). 244–248. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Pham‐Ledard Breakdown of academic impact, for papers by J. Zeffren Breakdown of academic impact, for papers by Martha Glenn Breakdown of academic impact, for papers by Chin-Yang Li Breakdown of academic impact, for papers by Katalin Kelemen Breakdown of academic impact, for papers by Julia Valencak Breakdown of academic impact, for papers by Adam M. Petrich Breakdown of academic impact, for papers by Kamel Laribi Breakdown of academic impact, for papers by Ana‐Iris Schiefer Breakdown of academic impact, for papers by Grete F. Lauritzsen
Rankless by CCL
2026